Skip to content

Postoperative Pain After Single-Cone Root Canal Obturation Using Three Sealers

Comparative Analysis of Postoperative Pain in Symptomatic Irreversible Pulpitis Teeth Following Single Cone Obturation Using Three Different Sealers: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07434141
Acronym
POP-RCT
Enrollment
75
Registered
2026-02-25
Start date
2025-06-08
Completion date
2026-05-30
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Irreversible Pulpitis (SIP), Symptomatic Irreversible Pulpitis With Apical Peridontitis

Keywords

Post endodontic pain, Symptomatic irreversible pulpitis, Single cone obturation

Brief summary

The goal of this clinical trial is to compare post-treatment pain after root canal therapy in adults with irreversible pulpitis using different root canal sealers. The study will also evaluate the need for pain medication after treatment. The main questions this study aims to answer are: Does the type of root canal sealer affect the intensity of pain after treatment? Does the type of sealer influence the number of analgesic tablets taken by participants? How does pain change over time after treatment with different sealers? Researchers will compare two bioceramic sealers (EndoSeal TCS and NeoSeal) with a resin-based sealer (AH Plus) to determine their effects on post-endodontic pain. Participants will: Receive root canal treatment using one of the study sealers Report their pain intensity at specific time points after treatment Record the number of analgesic tablets taken during the follow-up period

Interventions

PROCEDUREEndoseal TCS

Bioceramic, premixed calcium silicate-based root canal sealer used for obturation with the single-cone technique during root canal treatment

PROCEDURENeosealer

Fast-setting calcium silicate-based bioceramic root canal sealer used for obturation with the single-cone technique during root canal treatment

PROCEDUREAH Plus

Epoxy resin-based root canal sealer used for obturation with the single-cone technique during root canal treatment

Sponsors

Tehran University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 60 years * Adequate oral and dental hygiene * Prolonged positive response to cold test and electric pulp testing * Clinical diagnosis of symptomatic irreversible pulpitis and symptomatic apical periodontitis in a first or second molar (maxillary or mandibular) * Pulp exposure during caries removal accompanied by severe and profuse hemorrhage * No radiographic evidence of periapical lesions * Teeth with adequate restorative potential * Absence of periodontal disease

Exclusion criteria

* Teeth that are non-restorable * Presence of endodontic-periodontal (endo-perio) lesions * Teeth with radiographic evidence of periapical lesions * Teeth with internal or external root resorption * Patients with systemic diseases classified as ASA II or higher * Patients with a history of migraine * Teeth with over-obturation or under-obturation greater than 2 mm from the radiographic apex * Patients taking anti-anxiety medications * Procedural duration exceeding two hours * Known allergy to materials used in root canal treatment, including local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
Post-Endodontic Pain IntensityPain will be assessed at 6, 12,18, 24, and 48 hours post-treatmentPain intensity experienced by participants after root canal treatment will be measured using a Visual Analog Scale (VAS; 0-10 numeric rating scale), where: 0 = no pain 10 = worst imaginable pain Higher scores indicate greater pain intensity (worse outcome). Participants will also record the number of analgesic tablets consumed during the first 48 hours after treatment. The maximum VAS pain score recorded during the first 48 hours will be considered the primary outcome

Secondary

MeasureTime frameDescription
Analgesic ConsumptionWithin 48 hours post-treatmentTotal number of analgesic tablets consumed by participants during the first 48 hours after treatment

Countries

Iran

Contacts

PRINCIPAL_INVESTIGATORShole Ghabraei, Professor

Tehran university of medical science, school of dentistry

PRINCIPAL_INVESTIGATORHadi Assadian, Assistant Professor

Tehran university of medical science, school of dentistry

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026